Record Details

CMFRI develops anti-obesity medicine from marine organism Business Standard dated 16th February 2017

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/11559/
http://www.business-standard.com/article/news-ians/cmfri-develops-anti-obesity-medicine-from-marine-organism-117021500788_1.html
 
Title CMFRI develops anti-obesity medicine from marine organism Business Standard dated 16th February 2017
 
Creator CMFRI, Library
 
Subject CMFRI News Clippings
 
Description Kochi-headquartered Central Marine Fisheries Research Institute (CMFRI) has developed an anti-obesity nutraceutical from seaweeds, the institute said on Wednesday. Kerala Governor Justice P Sathasivam will release the product during the CMFRI Platinum Jubilee celebrations inaugural function on Saturday, it said in a statement. CMFRI scientists prepared the product named CadalminTM Antihypercholesterolemic extract (CadalminTM ACe) from seaweeds which are commonly available in the Indian coastal waters and are known for their extraordinary medicinal properties. Kajal Chakraborty, Senior Scientist in Marine Biotechnology Division of CMFRI, who developed the product, said CadalminTM Antihypercholesterolemic extract can be administered to regulate clinical indicators leading to dyslipidemia or obesity, total adipose tissue and visceral fat, triglycerides besides cholesterol.
 
Publisher Business Standard
 
Date 2017-02-16
 
Type Other
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/11559/1/Business%20Standard_16-02-2017.pdf
CMFRI, Library (2017) CMFRI develops anti-obesity medicine from marine organism Business Standard dated 16th February 2017. Business Standard.